Skip to main content
SpringerLink
Log in

Factor VIII

Coagulation disorders in a child, treated with recombinant-activated factor VII and rituximab: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Blatny J, Kohlerova S, Zapletal O, Fiamoli V, Penka M, Smith O.Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors. Haemophilia 14: 1140-1142, No. 5, Sep 2008 - Czech Republic

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Factor VIII. React. Wkly. 1227, 13 (2008). https://doi.org/10.2165/00128415-200812270-00037

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812270-00037

Keywords

Search

Navigation